Latest Advances

  • Condition: Autosomal Dominant Polycystic Kidney Disease
  • Journal: Urologiia (Moscow, Russia : 1999)
  • Treatment Used: Simultaneous Laparoscopic Bilateral Nephrectomy
  • Number of Patients: 6
  • Published —
The study researched the use of simultaneous laparoscopic bilateral nephrectomy as preparation for kidney transplantation in patients with autosomal dominant polycystic kidney disease.
  • Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  • Journal: Clinical journal of the American Society of Nephrology : CJASN
  • Treatment Used: Tolvaptan
  • Number of Patients: 1803
  • Published —
This study evaluated the safety of long-term tolvaptan in later-stage autosomal dominant polycystic kidney disease (formation of multiple cysts in the kidneys; ADPKD).
  • Condition: Premature Baby with Severe Oligohydramnios and Hypotension
  • Journal: Journal of Korean medical science
  • Treatment Used: medications, peritoneal dialysis, and respiratory support,
  • Number of Patients: 1
  • Published —
This case report discusses a premature boy diagnosed with renal tubular dysgenesis (abnormal kidney development; RTD) treated with medications, peritoneal dialysis, and respiratory support.
  • Condition: COVID-19 in Kidney Transplant Recipient
  • Journal: BMJ case reports
  • Treatment Used: Immunosuppressive Therapy with Tacrolimus and Low-Dose Prednisolone
  • Number of Patients: 1
  • Published —
This case report describes a 62-year-old female kidney transplant recipient with a mild COVID-19 treated with immunosuppressive therapy with tacrolimus and low-dose prednisolone.
  • Condition: Congenital Hepatic Fibrosis (CHF) in Children
  • Journal: Pathology international
  • Treatment Used: Living Donor Liver Transplantation (LDLT)
  • Number of Patients: 14
  • Published —
This study clarified the prognosis of children with congenital hepatic fibrosis (CHF) who received living donor liver transplantation (LDLT) from donors who might be heterozygous carriers of a hepatorenal fibrocystic disease.
  • Condition: Patients with Autosomal Dominant Polycystic Kidney Disease on V2 Receptor Antagonists (ADPKD)
  • Journal: International urology and nephrology
  • Treatment Used: Dietary Intervention
  • Number of Patients: 30
  • Published —
This study identified the contribution of sodium and urea excretion rate to daily urine output, and to evaluate the effectiveness of dietary counseling on sodium and urea excretion rates in patients with autosomal dominant polycystic kidney disease (ADPKD).
  • Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  • Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
  • Treatment Used: Tolvaptan and Octreotide
  • Number of Patients: 0
  • Published —
This review analyzed the main trials published to date demonstrating the effects on disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD), and illustrated the indications for identifying subjects eligible for therapy.
  • Condition: Autosomal Dominant Polycystic Kidney Disease
  • Journal: Combinatorial chemistry & high throughput screening
  • Treatment Used: Tolvaptan
  • Number of Patients: 1536
  • Published —
In this review of the literature, researchers evaluated the safety and effectiveness of tolvaptan for the treatment of autosomal dominant polycystic kidney disease.
  • Condition: Peritoneal Dialysis (PD) Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  • Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • Treatment Used: Unilateral Nephrectomy vs. Renal Arterial Embolization
  • Number of Patients: 37
  • Published —
This study compared the technique of survival of peritoneal dialysis (PD) after transcatheter renal artery embolization with that of nephrectomy in patients with autosomal dominant polycystic kidney disease (ADPKD).
  • Condition: Neonatal Polycystic Kidney Disease
  • Journal: Medicine
  • Treatment Used: Infection Treatment
  • Number of Patients: 1
  • Published —
This case report describes a 27-day-old male neonate diagnosed with polycystic kidney disease whose infection was treated before referral.
  • Condition: Pediatric Liver-Kidney and Multi-Visceral-Kidney Transplantation
  • Journal: Pediatric transplantation
  • Treatment Used: Pediatric Donor en Bloc Kidneys with Bladder Segment
  • Number of Patients: 4
  • Published —
This study reported experience with donor kidneys, ureters, and a bladder patch en bloc with multi-visceral organs in pediatric liver-kidney and multi-visceral-kidney transplantation.
  • Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  • Journal: International urology and nephrology
  • Treatment Used: Mammalian Target of Rapamycin (mTOR) Inhibitors
  • Number of Patients: 784
  • Published —
This review of the literature analyzed therapeutic and adverse effects of mammalian target of rapamycin (mTOR) inhibitors in patients with autosomal dominant polycystic kidney disease (ADPKD).
Showing 1-12 of 33